Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level

Journal of Clinical Microbiology

Volumn 35, Issue 3, 1997, Pages 719-723

  Telenti, A ^a   Honore N ^b   Bernasconi, C ^a   March, J ^c   Ortega, A ^c   Heym, B ^b,d   Takiff, H E ^e   Cole, S T ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSTITUT PASTEUR   (France)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HÔPITAL AMBROISE PARÉ   (France)

^e INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENOTYPE; LABORATORY TEST; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STRAIN DIFFERENCE;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0031057723     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.3.719-723.1997     Document Type: Article

References (28)

1. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, S. K. Um, T. Wilson, D. Collins, G. De Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
2. Cole, S. T. 1994. Mycobacterium tuberculosis: drug resistance mechanisms. Trends Microbiol. 2:411-415.
3. Cole, S. T. 1996. Rifamycin resistance in mycobacteria. Res. Microbiol. 147:48-52.
4. Cooksey, R. C., G. P. Morlock, A. McQueen, S. E. Glickman, and J. T. Crawford. 1996. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from New York City. Antimicrob. Agents Chemother. 40:1186-1188.
5. De Beenhouwer, H., Z. Lhiang, G. Jannes, W. Mijs, L. Machtelinck, R. Rossau, H. Traore, and F. Portaels. 1995. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis. 76:425-430.
6. Delgado, M. B., and A. Telenti. 1996. Detection of mutations associated with quinolone resistance in Mycobacterium tuberculosis, p. 138-143. In D. H. Persing (ed.), Selected PCR protocols for emerging infectious diseases. American Society for Microbiology, Washington, D.C.
7. Deretic, V., W. Philipp, S. Dhandayuthapani, M. H. Mudd, R. Curcic, T. Garbe, B. Heym, L. E. Via, and S. T. Cole. 1995. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol. Microbiol. 17:889-900.
8. Heifets, L. B. 1991. Drug susceptibility in the chemotherapy of mycobacterial infection. CRC Press, Boca Raton, Fla.
9. Heym, B., P. M. Alzari, N. Honoré, and S. T. Cole. 1995. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol. Microbiol. 15:235-245.
10. Heym, B., N. Honoré, C. Truffot-Pernot, A. Banerjee, C. Schurra, W. R. Jacobs, Jr., J. D. A. van Embden, J. H. Grosset, and S. T. Cole. 1994. Implications of multidrug resistance for the future of short course chemotherapy of tuberculosis: a molecular study. Lancet 344:293-298.
11. Kapur, V., L. Ling-Ling, M. R. Hamrick, B. B. Plikaytis, T. M. Shinnick, A. Telenti, W. R. Jacobs, Jr., A. Banerjee, S. Cole, K. Y. Yuen, J. E. Clarridge III, B. Kreiswirth, and J. M. Musser. 1995. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. Med. 119:138-130.
12. Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. van Soolingen, and J. D. A. van Embden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
13. Ristow, M., M. Moehling, M. Rifai, H. Schatz, K. Feldmann, and A. Pfeiffer. 1995. New isoniazid/ethionamide resistance gene mutation and screening for multi-drug resistant Mycobacterium tuberculosis strains. Lancet 346:502-503.
14. Rouse, D. A., Z. Li, G. H. Bai, and S. L. Morris. 1995. Characterization of the inhA and katG genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:2472-2477.
15. Salfinger, M., and G. E. Pfyffer. 1994. The new diagnostic mycobacteriology laboratory. Eur. J. Clin. Microbiol. Infect. Dis. 13:961-979.
16. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Med. 2:662-667.
17. Sherman, D. R., P. J. Sabo, M. J. Hickey, T. M. Arain, G. G. Mahairas, Y. Yuan, C. E. Barry III, and C. K. Stover. 1995. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc. Natl. Acad. Sci. USA 92:6625-6629.
18. Soeckle, M. Y., L. Guan, N. Riegler, I. Weitzman, B. Kreiswirth, J. Kornblum, F. Laraque, and L. W. Riley. 1993. Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J. Infect. Dis. 168:1063-1065.
19. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
20. Telenti, A. 1997. Genetics of drug resistance in tuberculosis. Clin. Chest Med. 18:5.1-5.10.
21. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. T. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
22. Telenti, A., P. Imboden, F. Marchesi, T. Schmidheini, and T. Bodmer. 1993. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism. Antimicrob. Agents Chemother. 37:2054-2058.
23. Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bottger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.
24. Telenti, A., and D. H. Persing. 1996. Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis. Res. Microbiol. 147:73-79.
25. Telenti, A., W. Philipp, S. Sreevatsan, C. Bernasconi, K. E. Stockbauer, B. Wieles, J. M. Musser, and W. R. Jacobs, Jr. The emb operon, a unique gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med., in press.
26. Torrea, G., C. Offredo, M. Simonet, B. Gicquel, P. Berche, and C. Pierre-Audigier. 1996. Evaluation of tuberculosis transmission in a community by 1 year of systematic typing of Mycobacterium tuberculosis clinical isolates. J. Clin. Microbiol. 34:1043-1049.
27. Wilson, T. M., and D. M. Collins. 1996. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 19: 1025-1034.
28. Zhang, Y., B. Heym, B. Allen, D. Young, and S. T. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:501-593.